Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
Clinical trial NCT06510660 · RECRUITING
Trial details
- NCT number
- NCT06510660
- Sponsor
- Fujian Medical University Union Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-11
- Primary completion
- 2025-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.